Benzodiazepines, alcohol and driving performance

Phase 2

Recruiting

• Conditions: Drugged driving; Injuries and Accidents - Other injuries and accidents; Mental Health - Studies of normal psychology, cognitive function and behaviour; Public Health - Other public health

• Registration Number: ACTRN12618000727246
• Lead Sponsor: Swinburne University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-02
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Male or female, aged 21 to 40 years;
Willing and able to provide written informed consent;
Understands and is willing and able to comply with all study procedures;
Fluent in written and spoken English;
Must have normal or corrected-to-normal vision;
In good general health as judged by the investigator and research nurse;
Non-smoker;
Social drinker, who is experienced with consuming two alcoholic drinks on a single occasion, typically in a social setting;
Experience with benzodiazepines;
Is a regular driver (> 4,000 km/year) with three years of driving with a full driver’s licence;
Less than 95kg in weight (due to the weight related dosing of alcohol);
Willing to abstain from the following prior to their scheduled visit:
oNo food or drinks (except water) within 2 hours prior to testing
oNo caffeine-containing products within 12 hours prior to testing
oNo alcohol within 24 hours prior to testing
oNo drugs/medication for at least 1 week prior to testing (except for prophylactic antibiotics, contraceptive pill or other routine medications to treat benign conditions, such as antibiotics to treat acne).
oNo driving or riding a bicycle or motorbike from the site
oNo driving, riding, operating heavy machinery for 24 hours after leaving the site
oNo alcohol, drugs, or medication (unless you have consulted with your doctor) for 24 hours after leaving the site

Exclusion Criteria

Unable to understand or comply with testing procedures;
Inability to speak or read English;
History of drug or substance abuse or current illicit drug abuse;
History of neurological conditions or previous or current history of psychiatric, cardiac, endocrine, gastrointestinal, or bleeding disorders;
Pregnant, potentially pregnant or lactating;
Taking any form of ongoing medication (except for prophylactic antibiotics, contraceptive pill or other routine medications to treat benign conditions, such as antibiotics to treat acne);
Unable to participate in scheduled visit, treatment plan, tests and other study procedures according to the protocol;
Current participation in any other studies involving investigational or marketed products within 30 days prior to the screening visit;
Have previously participated in this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified